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Abstract
Background: Extracorporeal Shockwave Lithotripsy (ESWL) is a safe and noninvasive management for upper urinary tract calculi. It
is potentially a painful procedure. There are different analgesic agents for pain relief during ESWL. Successful treatment depends on
good management of pain. Therefore, a standard protocol is needed for administering an analgesic agent. This study was designed
to compare the efficacy and side effects of paracetamol and fentanyl for pain control during extracorporeal shock wave lithotripsy.
Methods: In this randomized clinical trial, 102 patients with upper urinary tract stones undergoing SWL were randomly divided to
two groups. Group P received 15 mg/kg of paracetamol 10 minutes before the procedure, and group F received 1 µg/kg intravenous
fentanyl three minutes before the procedure. Pain scores were assessed with the 10-score linear Visual Analogue pain Scale (VAS). The
VAS scores, systolic and diastolic blood pressure, and peripheral oxygen saturation were recorded before the procedure and every
10 minutes during the ESWL. Side effects (nausea and vomiting) and satisfaction scores were recorded.
Results: There were no statistically significant differences in VAS scores between the two groups, except for those at 30 minutes,
at which group P showed a higher VAS value. There were less supplemental analgesia requirement and side effects in the P group
compared with fentanyl.
Conclusions: This study showed that paracetamol could be an effective and safe alternative analgesic for pain control during ESWL.
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1. Background
Urolithiasis is considered as the third most common
urological disease. Increased changes in the worldwide
incidence and prevalence of nephrolithiasis have been re-
ported (1, 2). Extracorporeal shock wave lithotripsy was in-
troduced for the first time in 1980 and it revolutionized
urolithiasis treatment and replaced open stone surgery
(3, 4). It is a useful, safe, and noninvasive management
of urinary stones. Despite the introduction of modern
lithotriptors, pain is common among patients undergoing
the ESWL procedure. Good pain management after surgery
is important for optimal stone fragmentation. The ESWL
procedure can be carried out on an outpatient basis. Most
patients need appropriate analgesia with minimal adverse
effects. There are different analgesic agents for pain re-
lief during ESWL, including opioid, NSAIDS, and local anes-
thetic agents. Successful treatment depends on good man-
agement of pain. Therefore, a standard protocol is needed
for administering the analgesic agent (3, 5, 6). The aim of
this randomized single blinded study was to compare the
efficacy and side effects of paracetamol and fentanyl for
pain control during extracorporeal shock wave lithotripsy.
2. Methods
In this randomized single-blind clinical trial, 102 pa-
tients (74 males and 28 females) undergoing shock wave
lithotripsy at a referral nephrology center in 2015 and 2016
were enrolled. This study was registered at the Iranian reg-
istry of clinical trial (IRCT) and allocated a unique code
(Identifier IRCT2016072329034N1). After the clinical trial
study was approved by the local ethical committee and
written informed consents were obtained, the patients
were randomly assigned to receive either 1 µg/kg intra-
venous fentanyl three minutes before ESWL (group F) or 15
mg/kg intravenous paracetamol ten minutes before ESWL.
A third-generation lithotripter (Dornier HM-3) was used for
ESWL lithotripter.
Inclusion criteria were age of 20 to 65 years, being
scheduled for elective ESWL with American society of anes-
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thesiologists (ASA) physical status I or II, and having up-
per ureteral stones of 6 to 20 mm. Exclusion criteria
were history of chronic use of analgesics or alcohol, use
of any analgesic drug within three days before the proce-
dure, allergy study drugs, treatment with sedative or anti-
depressant drugs, signs and symptoms of urinary tract
infection, allergy to study drugs, moderate to severe hy-
droureteronephrosis, presence of multiple and/or bladder
and/or radiolucent stones, pregnancy, and sensory neuro-
logical disease.
The visual analogue scale (VAS) with 10-score linear vi-
sual analogue pain scale ranging from zero (no pain) to
ten (greatest pain), during SWL, was compared between
the groups. When VAS value was greater than three, sup-
plemental analgesia was administered to both groups.
Twenty-five micrograms of intravenous fentanyl was given
in this condition. Electrocardiogram (ECG) and pulse
oximeters were used to monitor patient’s need for oxy-
gen therapy. While the saturation was less than 86%, face
masks were used for supplementary oxygen. Side effects
ranged from one to three; one was related to no nausea,
two related to nausea without vomiting and nausea with
vomiting was shown with a score of three. Age, gender,
weight, stone size, ASA physical status, and side effects
were recorded.
All statistical analyses were conducted with SPSS, ver-
sion19. Quantitative data was expressed as mean ± stan-
dard deviation and qualitative data was also demonstrated
as frequencies and percentages. Statistical analysis was
done using chi-square, Kolmogorov-Smirnov, and Mann-
Whitney-U tests. P values of less than 0.05 were regarded
statistically significant.
3. Results
The mean age of patients was 43.4 ± 13.2 years. 34 pa-
tients were males and 28 were females. The mean weight
of patients was 78.8 ± 11.8 kilograms and the mean stone
size was 11.08 ± 4.1 millimeters. There was no significant
difference in gender, ASA physical status, age, and systolic
and diastolic arterial pressure between the groups (Tables
1 and 2).
Supplemental analgesia requirement was significantly
lower in the P group compared with the F group and also
the P group had fewer side effects than the F group (Table 3).
There was higher peripheral O2 saturation in the P group
(Table 4).
4. Discussion
Effective analgesia during ESWL is essential for good
outcomes. Various opioid agents (morphine, pethidine,
Table 1. Demographic Data of Both Groupsa
Variables Group P Group F P-Value
Age (yr) 41.9 ± 13.02 44.8 ± 13.4 0.271
Gender (male/female) 41/10 33/18 0.076
ASA physical status (I/II) 42/9 40/11 0.681
Weight 77.2 ± 11.4 80.47 ± 12.2 0.183
Stone size 10.5 ± 3.8 11.6 ± 4.3 0.143
Abbreviations: ASA; American society of anesthesiologists, P group; Paraceta-
mol group, F group; Fentanyl group.
a Values are represented as mean ± SD and ratio for sex and ASA status.
and fentanyl) are well known for the management of pain
during SWL yet their main adverse effects, such as decrease
in oxygen saturation, nausea, vomiting, drowsiness, and
hypersensitivity, have led to their replacement with anal-
gesia. Paracetamol is a relatively safe and effective anal-
gesic. It is the most commonly used analgesic worldwide
for other indications. In cases of severe pain, it can reduce
the consumption of opioids (3, 6, 7).
Although opioids are commonly used drugs for pain
control during ESWL, other analgesics with less adverse ef-
fects can be effective alternatives in pain control. Paraceta-
mol has recently been considered for its safety compared
with other analgesia (3). The present study characterized
the comparative effects of paracetamol and fentanyl on
pain relief during extracorporeal shock wave.
Akcali et al. studied 90 patients and concluded that
one gram of paracetamol is significantly effective in com-
parison with lornoxicam and tramadol. The mean VAS
scores were similar among these three groups at all mea-
sured times during SWL, except for those at five and twenty
minutes, at which the paracetamol group showed better
pain control. They also found paracetamol as an effective
and safe agent in pain control during SWL as reported by
the current study. There was no significant difference be-
tween the three groups regarding supplemental drug con-
sumption (8). In concomitance with this study, Eker et
al. demonstrated that IV paracetamol reduces propofol-
ketamine consumption during ESWL procedures in pedi-
atric patients (9).
The current study showed that paracetamol could be
used for pain control during ESWL. There were no signifi-
cant statistical differences in VAS scores between the two
groups except for those at 30 minutes, at which group P
showed a higher VAS value. However, there was less supple-
mental analgesia requirement in the paracetamol group.
Based on the current results, paracetamol is an effective
analgesic with significantly fewer side effects in compari-
son with fentanyl and there was higher peripheral O2 satu-
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Table 2. Diastolic and Systolic Arterial Pressure Data of Both Groupsa
Diastolic Blood Pressure Systolic Blood Pressure
Group P Group F P-Value Group P Group F P-Value
Baseline 75.8 ± 7.8 79.5 ± 10.6 0.005 122.5 ± 11.1 130.1 ± 10.9 0.0001
10min 76.4 ± 8.2 79 ± 9.9 0.12 123 ± 10.2 124.8 ± 18.7 0.05
20min 77.7 ± 8 78 ± 8.7 0.55 123.1 ± 10.2 126.4 ± 10.3 0.11
30min 77.4 ± 8.4 75.2 ± 9.1 0.15 124 ± 10.5 124.7 ± 8.5 0.57
After ESWL 77.1 ± 6.3 75.2 ± 8.8 0.73 119.1 ± 7.8 121.9 ± 8.0 0.02
Abbreviations: F group; Fentanyl group, P group; Paracetamol group.
a Values are represented as mean ± SD.
Table 3. Supplement Drug User and Side Effects after the ESWL Procedurea
Group P Group F P-Value
Supplement drug user 14 (27.5) 32 (62.7) 0.001
Nauseawithout vomiting 2 (3.9) 14 (27.5)
0.0001
Nauseawith vomiting 0 (0) 3 (5.8)
Abbreviations: F group; Fentanyl group, P group; Paracetamol group.
a Values are represented as No. (%)
Table 4. Peripheral Saturation O2 Data of Both Groups
a
Group P Group F P-Value
Baseline 90.6 ± 1.2 90.0 ± 1.8 0.0001
10min 91.6 ± 1.2 90.9 ± 1.7 0.0001
20min 91.3 ± 1.1 89.7 ± 1.3 0.0001
30min 90.6 ± 1.3 89.4 ± 1.3 0.0001
After ESWL 92.9 ± 1.6 91.9 ± 1.2 0.0001
Abbreviations: A group; Acetaminophen group, F group; Fentanyl group.
a Values are represented as mean ± SD.
Table 5. Comparisons of Mean Visual Analog Scale Scores in the Two Groups
Group P Group F P-Value
Baseline 1.90 ± 1.5 2.64 ± 2.5 0.35
10min 2.64 ± 1.6 2.62 ± 1.9 0.50
20min 3.37 ± 1.6 3.00 ± 1.9 0.17
30min 3.47 ± 1.8 2.49 ± 1.7 0.0001
At the end of ESWL 1.57 ± 0.7 1.70 ± 1.2 0.8
Abbreviations: F group; Fentanyl group, P group; Paracetamol group, VAS; vi-
sual analog scale.
ration in the P group.
In contrast, Ozkan et al. evaluated the comparison
of pain relief effect of paracetamol, lornoxicam, and tra-
madol as additional administration analgesics on patients
during shockwave lithotripsy. Patients were divided to
three groups and all of them were given tramadol. The
mean VAS scores were lower in the group, which received
lornoxicam in comparison with paracetamol and only tra-
madol (10). In concomitance with this research, Yesil et
al. conducted a study on efficacy of diclofenac, dexketo-
profen, and hyoscine plus paracetamol. Patients received
analgesics half an hour before the ESWL procedure. It has
been reported that diclofenac sodium is more effective
compared with other groups and mixture of hyoscine plus
paracetamol reduces the VAS scores. Therefore, if hyoscine
plus paracetamol had been given an hour before opera-
tion, it might have been better than dexketoprofen and di-
clofenac (11).
Andreou et al. evaluated the effects of piroxicam anal-
gesia and tramadol analgesia on pain control during elec-
tromagnetic extracorporeal lithotripsy. They conducted a
randomized, double blind, clinical trial on 170 patients, di-
vided to two groups. Pain and discomfort score was mea-
sured by VAS. This study reported that both piroxicam and
tramadol are suitable for the treatment of pain during out-
patient extracorporeal lithotripsy. However, tramadol had
more side effects (12).
Overall, according to the current results, it may be con-
cluded that paracetamol can be an effective and safe alter-
native analgesic for pain control during ESWL and use of
this analgesic is recommended. However, further studies
with larger sample size and multi-center sampling is re-
quired to attain more definite results.
Ann Anesth Crit Care . 2018; 3(1):e66279. 3
Abdinezhad A et al.
References
1. Edvardsson VO, Indridason OS, Haraldsson G, Kjartansson O, Palsson
R. Temporal trends in the incidence of kidney stone disease. Kidney
Int. 2013;83(1):146–52. doi: 10.1038/ki.2012.320. [PubMed: 22992468].
2. Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of
prevalence, incidence, and associated risk factors. Rev Urol. 2010;12(2-
3):e86–96. [PubMed: 20811557]. [PubMed Central: PMC2931286].
3. Bach C, Zaman F, Kachrilas S, Kumar P, Buchholz N, Masood J. Drugs
for Pain Management in Shock Wave Lithotripsy. Pain Res Treatment.
2011;2011:1–7. doi: 10.1155/2011/259426.
4. El-Husseiny T, Buchholz N. The role of open stone surgery. Arab J
Urolog. 2012;10(3):284–8. doi: 10.1016/j.aju.2012.03.004.
5. Mousavi SA, Karami H, Barzegarnejad A. The effect of extracor-
poreal shock wave lithotripsy in the management of idiopathic
gallstones in children. J Indian Assoc Pediatr Surg. 2014;19(4):218–21.
doi: 10.4103/0971-9261.142010. [PubMed: 25336804]. [PubMed Central:
PMC4204247].
6. Liu J, Zang YJ. Comparative study between three analgesic agents for
the pain management during extracorporeal shock wave lithotripsy.
Urol J. 2013;10(3):942–5. [PubMed: 24078500].
7. Gupta NP, Kumar A. Analgesia for pain control during extracorporeal
shock wave lithotripsy: Current status. Indian J Urol. 2008;24(2):155–8.
[PubMed: 19468389]. [PubMed Central: PMC2684259].
8. Akcali GE, Iskender A, Demiraran Y, Kayikci A, Yalcin GS, Cam K,
et al. Randomized comparison of efficacy of paracetamol, lornoxi-
cam, and tramadol representing three different groups of analgesics
for pain control in extracorporeal shockwave lithotripsy. J Endourol.
2010;24(4):615–20. doi: 10.1089/end.2009.0483. [PubMed: 20184444].
9. Eker HE, Cok OY, Ergenoglu P, Aribogan A, Arslan G. IV paracetamol
effect on propofol-ketamine consumption in paediatric patients un-
dergoing ESWL. J Anesth. 2012;26(3):351–6. doi: 10.1007/s00540-012-
1335-4. [PubMed: 22349746].
10. Ozkan F, Erdemir F, Erkorkmaz U, Kaya Z, Senayli Y, Parlaktas BS.
Comparison of three different analgesic protocols during shockwave
lithotripsy. J Endourol. 2012;26(6):691–6. doi: 10.1089/end.2011.0004.
[PubMed: 22050496].
11. Yesil S, Polat F, Ozturk U, Dede O, Imamoglu M, Bozkirli I. Effect
of different analgesics on pain relief during extracorporeal shock
wave lithotripsy. Hippokratia. 2014;18(2):107–9. [PubMed: 25336870].
[PubMed Central: PMC4201393].
12. Andreou A, Sibert L, Montes R, Hacpille L, Pfister C, Grise P. [Random-
ized study comparing piroxicam analgesia and tramadol analgesia
during outpatient electromagnetic extracorporeal lithotripsy]. Prog
Urol. 2006;16(2):155–9. [PubMed: 16734237].
4 Ann Anesth Crit Care . 2018; 3(1):e66279.
